Population Size Estimation of Drug Users in Isfahan City (Iran) Using Network Scale-up Method in 2018

2018年利用网络规模放大法对伊朗伊斯法罕市吸毒者人口规模进行估算

阅读:1

Abstract

BACKGROUND: To provide prevention programs and educate drug users (DUs), the estimation of their population is necessary. This study aimed to estimate the population size of this hidden group in Isfahan city as a metropolitan in Iran using the network scale-up ýmethod (NSUM). METHODS: This cross-sectional study was performed in summer 2018 on 1000 people selected through a multistage sampling method based on 14 region of the municipality of Isfahan. The data collection tool was a questionnaire that was previously used in Dr. Banshi's national plan without any changes. The Cronbach's alpha value of the questionnaire was 0.826. Using correction factors such as transparency of response and the ratio of social network size used in previous national studies, the number of people with high-risk behaviors was estimated. The results were analyzed through NSUM based on survey analysis. FINDINGS: Among all kinds of DUs, men were the largest consumers. The prevalence of use of opium, cannabis, heroin/crack, stimulants, ecstasy, hallucinogens, tramadol, zolpidem, tobacco, and drug injection was 2983, 2342, 613, 766, 86, 268, 1185, 213, 5869, 135 in 100000 people, among individuals of over 18 years of age. In both sexes, the prevalence of using opium and its nectar and illegal treatment with methadone and buprenorphine was higher in people of over 30 years of age, while the prevalence of consuming cannabis, ecstasy, tramadol, tobacco products, and stimulants was higher in the age group of 18 to 30 years. CONCLUSION: The results indicated that the prevalence of different DUs in Isfahan city, especially among men was higher than the reported average (especially in young men of 18-30 years of age). Since the prevalence of drug use varies based on the type of substance used among age groups, targeted preventive planning based on the type of drug used and age group is recommended.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。